Tech Company Financing Transactions
CellVoyant Funding Round
On 2/26/2024, CellVoyant landed $9.6 million in Seed funding from Octopus Ventures, Air Street Capital and Horizons Ventures.
Transaction Overview
Company Name
Announced On
2/26/2024
Transaction Type
Venture Equity
Amount
$9,635,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to scale the business, including doubling the team size over the next two years, expanding laboratory and experimental infrastructure, and advancing AI capabilities.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
40 Berkeley Square
Bristol, BS8 1HP
UK
Bristol, BS8 1HP
UK
Phone
Undisclosed
Website
Email Address
Overview
CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rafael Salas
Browse more venture capital transactions:
Prev: 2/26/2024: Mobly venture capital transaction
Next: 2/26/2024: FAMS venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs